First-in-human effects of PPT1 inhibition using the oral GNS561 in patients with primary and secondary liver malignancies Meeting Abstract
| Authors: | Harding, J. J.; Awada, A.; Decaens, T.; Roth, G.; Merle, P.; Kotecki, N.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Mezouar, S.; Menut, A.; Bestion, E.; Paradis, V.; Halfon, P.; Raymond, E.; Abou-Alfa, G. K. |
| Abstract Title: | First-in-human effects of PPT1 inhibition using the oral GNS561 in patients with primary and secondary liver malignancies |
| Meeting Title: | Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) |
| Journal Title: | Hepatology |
| Volume: | 74 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Nov 12-15 |
| Meeting Location: | Virtual |
| ISSN: | 0270-9139 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2021-10-01 |
| Start Page: | 642A |
| End Page: | 643A |
| Language: | English |
| ACCESSION: | WOS:000707188003124 |
| PROVIDER: | wos |
| DOI: | 10.1002/hep.32188 |
| Notes: | Meeting Abstract: 1053 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
